Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (101-110 of 313) with videos related to

Pageof 32
Sort By:
International Journal of Hematology|September 27, 2008
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Biomedicines|March 25, 2022
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR AssaySelena Mimmi, Domenico Maisano, Vincenzo Dattilo, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Coumarin- and Dipicolylamine-Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer PotentialVenkatesan Saravanan, Andrea Angeli, Francesco Melfi, et al.
Hematological Oncology|February 16, 2023
Myelodysplastic syndromes with ring sideroblastsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignanciesEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Expert Review of Hematology|May 15, 2024
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemiaAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|April 13, 2025
Rilzabrutinib for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 32

Showing results (101-110 of 313) with videos related to

Sort By:
Pageof 32
International Journal of Hematology|September 27, 2008
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Biomedicines|March 25, 2022
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR AssaySelena Mimmi, Domenico Maisano, Vincenzo Dattilo, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Coumarin- and Dipicolylamine-Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer PotentialVenkatesan Saravanan, Andrea Angeli, Francesco Melfi, et al.
Hematological Oncology|February 16, 2023
Myelodysplastic syndromes with ring sideroblastsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignanciesEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Expert Review of Hematology|May 15, 2024
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemiaAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|April 13, 2025
Rilzabrutinib for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 32